S&P 500   3,337.70 (-0.41%)
DOW   27,448.58 (-0.49%)
QQQ   276.20 (-0.36%)
AAPL   114.01 (-0.83%)
MSFT   207.35 (-1.00%)
FB   259.08 (+0.88%)
GOOGL   1,457.27 (-0.10%)
AMZN   3,159.62 (-0.45%)
TSLA   425.71 (+1.07%)
NVDA   532.80 (+2.19%)
BABA   276.82 (+0.29%)
CGC   14.48 (+1.90%)
MU   50.68 (+1.93%)
GE   6.06 (-2.26%)
AMD   82.15 (+3.36%)
T   28.18 (-0.70%)
F   6.60 (-1.35%)
ACB   4.80 (+0.42%)
GILD   62.02 (-1.32%)
NFLX   493.63 (+0.61%)
DIS   124.00 (-1.58%)
BA   162.96 (-1.88%)
BAC   23.74 (-1.45%)
S&P 500   3,337.70 (-0.41%)
DOW   27,448.58 (-0.49%)
QQQ   276.20 (-0.36%)
AAPL   114.01 (-0.83%)
MSFT   207.35 (-1.00%)
FB   259.08 (+0.88%)
GOOGL   1,457.27 (-0.10%)
AMZN   3,159.62 (-0.45%)
TSLA   425.71 (+1.07%)
NVDA   532.80 (+2.19%)
BABA   276.82 (+0.29%)
CGC   14.48 (+1.90%)
MU   50.68 (+1.93%)
GE   6.06 (-2.26%)
AMD   82.15 (+3.36%)
T   28.18 (-0.70%)
F   6.60 (-1.35%)
ACB   4.80 (+0.42%)
GILD   62.02 (-1.32%)
NFLX   493.63 (+0.61%)
DIS   124.00 (-1.58%)
BA   162.96 (-1.88%)
BAC   23.74 (-1.45%)
S&P 500   3,337.70 (-0.41%)
DOW   27,448.58 (-0.49%)
QQQ   276.20 (-0.36%)
AAPL   114.01 (-0.83%)
MSFT   207.35 (-1.00%)
FB   259.08 (+0.88%)
GOOGL   1,457.27 (-0.10%)
AMZN   3,159.62 (-0.45%)
TSLA   425.71 (+1.07%)
NVDA   532.80 (+2.19%)
BABA   276.82 (+0.29%)
CGC   14.48 (+1.90%)
MU   50.68 (+1.93%)
GE   6.06 (-2.26%)
AMD   82.15 (+3.36%)
T   28.18 (-0.70%)
F   6.60 (-1.35%)
ACB   4.80 (+0.42%)
GILD   62.02 (-1.32%)
NFLX   493.63 (+0.61%)
DIS   124.00 (-1.58%)
BA   162.96 (-1.88%)
BAC   23.74 (-1.45%)
S&P 500   3,337.70 (-0.41%)
DOW   27,448.58 (-0.49%)
QQQ   276.20 (-0.36%)
AAPL   114.01 (-0.83%)
MSFT   207.35 (-1.00%)
FB   259.08 (+0.88%)
GOOGL   1,457.27 (-0.10%)
AMZN   3,159.62 (-0.45%)
TSLA   425.71 (+1.07%)
NVDA   532.80 (+2.19%)
BABA   276.82 (+0.29%)
CGC   14.48 (+1.90%)
MU   50.68 (+1.93%)
GE   6.06 (-2.26%)
AMD   82.15 (+3.36%)
T   28.18 (-0.70%)
F   6.60 (-1.35%)
ACB   4.80 (+0.42%)
GILD   62.02 (-1.32%)
NFLX   493.63 (+0.61%)
DIS   124.00 (-1.58%)
BA   162.96 (-1.88%)
BAC   23.74 (-1.45%)
Log in
NASDAQ:IOSP

Innospec Stock Forecast, Price & News

$63.02
-0.93 (-1.45 %)
(As of 09/29/2020 01:14 PM ET)
Add
Compare
Today's Range
$62.76
Now: $63.02
$64.25
50-Day Range
$63.20
MA: $72.64
$82.87
52-Week Range
$56.71
Now: $63.02
$107.85
Volume3,007 shs
Average Volume119,463 shs
Market Capitalization$1.55 billion
P/E Ratio28.65
Dividend Yield1.65%
Beta1.28
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels. Its products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. The Performance Chemicals segment provides technology-based solutions for its customers' processes or products focused in the personal care, home care, agrochemical, and metal extraction markets. The Oilfield Services segment develops and markets products to prevent loss of mud in drilling operations; chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, which enable flow assurance and asset integrity. The Octane Additives segment produces and sells tetra ethyl lead (TEL) for use in automotive gasoline. This segment is also involved in environmental remediation business that manages the cleanup of redundant TEL facilities. The company sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction preparations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Read More
Innospec logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.86 out of 5 stars


Industry, Sector and Symbol

Industry Chemicals & allied products
Sub-IndustrySpecialty Chemicals
Current SymbolNASDAQ:IOSP
CUSIP45768S10
Phone303-792-5554

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.51 billion
Cash Flow$6.71 per share
Book Value$37.51 per share

Profitability

Net Income$112.20 million

Miscellaneous

Employees2,000
Market Cap$1.55 billion
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$63.02
-0.93 (-1.45 %)
(As of 09/29/2020 01:14 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive IOSP News and Ratings via Email

Sign-up to receive the latest news and ratings for IOSP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Innospec (NASDAQ:IOSP) Frequently Asked Questions

How has Innospec's stock price been impacted by COVID-19 (Coronavirus)?

Innospec's stock was trading at $72.47 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, IOSP stock has decreased by 13.0% and is now trading at $63.02.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Innospec?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Innospec in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Innospec
.

When is Innospec's next earnings date?

Innospec is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Innospec
.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) issued its quarterly earnings results on Tuesday, August, 4th. The specialty chemicals company reported ($0.18) EPS for the quarter, missing the Zacks' consensus estimate of $0.31 by $0.49. The specialty chemicals company had revenue of $244.90 million for the quarter, compared to analyst estimates of $278.65 million. Innospec had a net margin of 3.96% and a return on equity of 11.10%. The firm's revenue was down 32.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.12 EPS.
View Innospec's earnings history
.

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec announced a semi-annual dividend on Thursday, May 7th. Stockholders of record on Monday, May 18th will be given a dividend of $0.52 per share on Tuesday, May 26th. This represents a dividend yield of 1.5%. The ex-dividend date is Friday, May 15th.
View Innospec's dividend history
.

What price target have analysts set for IOSP?

1 brokerages have issued 12 month target prices for Innospec's stock. Their forecasts range from $95.00 to $95.00. On average, they anticipate Innospec's stock price to reach $95.00 in the next year. This suggests a possible upside of 50.7% from the stock's current price.
View analysts' price targets for Innospec
.

Are investors shorting Innospec?

Innospec saw a drop in short interest in August. As of August 31st, there was short interest totaling 302,900 shares, a drop of 24.4% from the August 15th total of 400,500 shares. Based on an average daily trading volume, of 98,200 shares, the short-interest ratio is currently 3.1 days. Approximately 1.3% of the shares of the company are sold short.
View Innospec's Short Interest
.

Who are some of Innospec's key competitors?

What other stocks do shareholders of Innospec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include NVIDIA (NVDA), Corning (GLW), Altria Group (MO), Ecolab (ECL), Eastman Chemical (EMN), Illumina (ILMN), Realty Income (O), Pfizer (PFE), Sherwin-Williams (SHW) and Weyerhaeuser (WY).

Who are Innospec's key executives?

Innospec's management team includes the following people:
  • Mr. Patrick S. Williams, Pres, CEO & Director (Age 54)
  • Mr. Ian P. Cleminson, Exec. VP & CFO (Age 53)
  • Dr. Philip J. Boon, COO & Exec. VP (Age 60)
  • Dr. Ian M. McRobbie, Chief Technology Officer and Sr. VP of Research & Technology (Age 70)
  • Mr. Brian R. Watt, Sr. VP of Corp. Devel. & Investor Relations (Age 60)

What is Innospec's stock symbol?

Innospec trades on the NASDAQ under the ticker symbol "IOSP."

How do I buy shares of Innospec?

Shares of IOSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Innospec's stock price today?

One share of IOSP stock can currently be purchased for approximately $63.02.

How big of a company is Innospec?

Innospec has a market capitalization of $1.55 billion and generates $1.51 billion in revenue each year. Innospec employs 2,000 workers across the globe.

What is Innospec's official website?

The official website for Innospec is www.innospecinc.com.

How can I contact Innospec?

Innospec's mailing address is 8310 SOUTH VALLEY HIGHWAY SUITE 350, ENGLEWOOD CO, 80112. The specialty chemicals company can be reached via phone at 303-792-5554 or via email at [email protected]

This page was last updated on 9/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.